Mechanistically analogous phenomena have been observed in other systems where protein-mediated drug sequestration reduces effective target engagement and produces resistance — for example, in cancer cells, LAPTM4B overexpression sequesters doxorubicin and delays nuclear delivery (Li et al. 2010), providing a precedent for protein-facilitated drug trapping as a resistance mechanism. The gene discussed is LAPTM4B; the disease is cancer.